1. Home
  2. NCSM vs BRNS Comparison

NCSM vs BRNS Comparison

Compare NCSM & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

N/A

Current Price

$72.48

Market Cap

170.3M

Sector

Energy

ML Signal

N/A

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

N/A

Current Price

$0.55

Market Cap

55.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NCSM
BRNS
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
55.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
NCSM
BRNS
Price
$72.48
$0.55
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
25.3K
33.6K
Earning Date
03-04-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
239.22
N/A
EPS
8.65
N/A
Revenue
$142,471,000.00
N/A
Revenue This Year
$5.57
N/A
Revenue Next Year
$4.81
N/A
P/E Ratio
$8.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.20
$0.51
52 Week High
$73.72
$2.91

Technical Indicators

Market Signals
Indicator
NCSM
BRNS
Relative Strength Index (RSI) 78.22 37.85
Support Level $33.92 N/A
Resistance Level N/A $0.76
Average True Range (ATR) 5.40 0.05
MACD 1.20 0.00
Stochastic Oscillator 94.82 26.19

Price Performance

Historical Comparison
NCSM
BRNS

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: